Building on a decade of successful business in North America, powder characterisation specialist Freeman Technology has formally established its US subsidiary, Freeman Technology Inc.
This new organisation will take responsibility for sales, service and applications support for the FT4 Powder Rheometer in the US, and will work with prospective customers across all industrial markets.
To support this move, Mike Delancy has joined Freeman Technology Inc as national sales specialist adding a wealth of commercial and rheological applications experience to the established Freeman Technology team.
Sales of the Freeman Technology FT4 Powder Rheometer have grown year-on-year since the instrument’s introduction more than 10 years ago, with North America an increasingly active market in the pharmaceutical and other powder processing sectors.
Freeman Technology formally establishes US subsidiary
Appoints Mike Delancy as national sales specialist
You may also like
Regulatory
Analytical vigilance saves lives
The EDQM has updated Ph. Eur. monographs to detect ethylene glycol and diethylene glycol. Butterworth Laboratories supports compliance through validated chromatographic testing, impurity screening, and documentation—helping pharmaceutical companies ensure product safety and protect patient lives
Analysis
Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds
Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals
People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Analysis
Leica Biosystems expands leading digital pathology portfolio for the US with multiple launches at Pathology Visions 2025
In a groundbreaking showcase of innovation designed to accelerate the digital transformation of pathology, Leica Biosystems proudly launches its latest software solutions in the Aperio Digital Pathology portfolio during Pathology Visions.